Credit performance metrics across specialty finance portfolios (net charge-off rates, non-performing loan ratios)
M&A announcements and integration execution updates given the conglomerate structure and recent growth trajectory
Net interest margin trends as Fed policy shifts affect funding costs and asset yields
Insurance segment organic growth rates and commission margin stability amid distribution channel shifts
high - Diversified financial services exhibit strong cyclical sensitivity. Specialty lending volumes and credit quality correlate directly with GDP growth and employment trends. Insurance distribution revenues depend on commercial activity and consumer spending patterns. Alternative asset management faces redemption pressure during economic downturns as institutional allocators reduce risk exposure. The 0.94 current ratio indicates limited liquidity cushion during stress periods.
Rising rates present mixed impacts. Specialty finance portfolios benefit from floating-rate asset repricing faster than funding costs, expanding net interest margins. However, higher rates compress loan origination volumes as borrower demand weakens, and increase the present value discount on long-duration fee streams, pressuring valuation multiples. The 27.1x EV/EBITDA suggests the market is pricing in significant growth, making the stock vulnerable to multiple compression if rates rise further and growth expectations moderate.
Regulatory fragmentation across insurance, lending, and asset management creates compliance complexity and potential enforcement actions that could restrict growth or impose penalties
Disintermediation from fintech platforms and direct-to-consumer digital channels eroding traditional insurance distribution and lending market share
Conglomerate discount as public markets increasingly favor pure-play specialists over diversified financial holding companies
momentum - The 204.9% one-year return and 161.2% three-month surge attract momentum and event-driven investors betting on continued M&A activity, restructuring catalysts, or sector rotation into financials. The -50.6% net income decline alongside massive price appreciation suggests speculative positioning rather than fundamental value. High volatility and 27.1x EV/EBITDA multiple indicate growth-at-any-price sentiment rather than traditional value or income orientation.
Trend
+9.0% vs SMA 50 · +42.7% vs SMA 200
Momentum
Volume distribution is neutral or leaning toward distribution. No compelling squeeze setup based on current money flow data.
Based on volume distribution analysis. Direct short interest data (short float %, days to cover) is not available in current data sources.
ANALYST ESTIMATES
Analyst consensus estimates · Actuals replace estimates as reported
| Year | Revenue Est. | Rev Gth | EPS Est. | EPS Gth | Range | Analysts |
|---|---|---|---|---|---|---|
FY2024 | $4.0B $4.0B–$4.0B | — | $1.48 | — | ±1% | Low1 |
FY2025 | $5.3B $5.3B–$5.3B | ▲ +33.8% | $1.74 | ▲ +17.2% | ±2% | Moderate3 |
FY2026(current) | $5.7B $5.7B–$5.7B | ▲ +7.8% | $2.21 | ▲ +27.2% | ±1% | Moderate4 |
INSTITUTIONAL OWNERSHIP
PACS News
About
No description available.
| Symbol | Price | Day % | Mkt Cap↓ | P/E | Rev Grw | Margin | ELO |
|---|---|---|---|---|---|---|---|
PACS◀ | $37.48 | +0.00% | $5.9B | — | — | — | 1500 |
| $66.13 | -5.07% | $13.0B | — | +12626.1% | -14525.8% | 1500 | |
| $94.92 | -3.79% | $12.6B | — | +3288.2% | -4239.0% | 1500 | |
| $523.69 | -3.00% | $12.1B | — | +43205.3% | -3008.0% | 1500 | |
| $227.72 | -1.30% | $11.7B | — | +6554.5% | -2868.8% | 1500 | |
| $57.90 | -0.86% | $11.2B | 50.3 | +1459.3% | 147.7% | 1500 | |
| $76.67 | -3.79% | $10.8B | — | +2325815.3% | -19.7% | 1500 | |
| Sector avg | — | -2.54% | — | 50.3 | +398824.8% | -4085.6% | 1500 |